Crown Bioscience, Inc.
A Director of Business Development at Crown Bioscience drives growth in the translational science and oncology sectors by developing and executing tailored sales strategies. The role involves identifying business opportunities, managing negotiations with prospective partners, and cultivating key internal and external relationships. Candidates must possess extensive drug discovery experience and a strong background in in vivo pharmacology.
Headquarters
San Diego, California, United States
Company Size
1001-5000 employees
Founded
2006
N/A
Preclinical evidence for the effective use of TL-895, a highly selective and potent second-generation BTK inhibitor, for the treatment of B-cell malignancies
Nov 21, 2023
Narazaciclib, a novel multi-kinase inhibitor with potent activity against CSF1R, FLT3 and CDK6, shows strong anti-AML activity in defined preclinical models
Apr 19, 2024
Comparison of Continuous Glucose Monitoring between Dexcom G4 Platinum and HD-XG Systems in Nonhuman Primates ( Macaca Fascicularis
Aug 29, 2017
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Crown Bioscience, Inc..
23% below the average for this role
Senior. Scientist, In Vivo Pharmacology
Merck & Co., Inc.
Senior. Scientist, In Vivo Pharmacology
Merck & Co., Inc.
Principal Scientist, In Vivo Pharmacology, Oncology
MSD
Principal Scientist, In Vivo Pharmacology, Oncology
Merck & Co., Inc.
Director/Senior Director, In Vivo Pharmacology
Rezo Therapeutics
Translational Biologist
Isomorphic Labs